NARI Inari Medical
- 45.580
- +1.830+4.18%
Inari Medical News
Inari Medical: A Strong Buy on Growth and Market Expansion Potential
Novo Nordisk, Flagship to Develop Next-generation Obesity Drugs
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
IRVINE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other
Director William Hoffman Sells Shares of Inari Medical Inc (NARI)
Inari Medical(NARI.US) Director Sells US$1.62 Million in Common Stock
$Inari Medical(NARI.US)$ Director Hoffman William sold 38,549 shares of common stock on May 1, 2024 at an average price of $42 for a total value of $1.62 million.Source: Announcement What is statement
Inari Medical Insider Sold Shares Worth $1,619,047, According to a Recent SEC Filing
William Hoffman, Director, on May 01, 2024, sold 38,549 shares in Inari Medical (NARI) for $1,619,047. Following the Form 4 filing with the SEC, Hoffman has control over a total of 965,359 shares of t
An Intrinsic Calculation For Inari Medical, Inc. (NASDAQ:NARI) Suggests It's 29% Undervalued
Key Insights The projected fair value for Inari Medical is US$58.89 based on 2 Stage Free Cash Flow to Equity Inari Medical's US$41.60 share price signals that it might be 29% undervalued Our fair
Analysts Are Bullish on Top Healthcare Stocks: Qiagen (QGEN), Inari Medical (NARI)
Canadian Investment Banking Group: Maintaining the Inari Medical (NARI.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $75.00 to $55.00.
Canadian Investment Banking Group: Maintaining the Inari Medical (NARI.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $75.00 to $55.00.
Inari Medical Is Maintained at Overweight by Wells Fargo
Inari Medical Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Overweight on Inari Medical, Lowers Price Target to $84
Wells Fargo analyst Larry Biegelsen maintains Inari Medical with a Overweight and lowers the price target from $100 to $84.
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) fell sharply during Wednesday's session as the company reported first-quarter results and issued revenue guidance for the second quarter.AMD guided
Inari Medical (NARI) Q1 Earnings Miss Estimates, OpEx Rises
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index gaining over 50 points on Wednesday.Shares of Powell Industries, Inc. (NASDAQ:POWL) rose sharply during Wednesday's session after the company reported
Inari Medical Price Target Cut to $50.00/Share From $55.00 by Piper Sandler
Inari Medical Price Target Cut to $50.00/Share From $55.00 by Piper Sandler
Bank of America Securities Sticks to Their Buy Rating for Inari Medical (NARI)
Inari Medical Shares Climb After Outlook Raise, Strong 1Q Revenue
By Dean Seal Shares of Inari Medical jumped after the company raised its 2024 revenue guidance and beat analysts' top line expectations for the first quarter. The stock was up 11% at $41.42 in prema
Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Shares of Pinterest, Inc (NYSE:PINS) rose sharply in today's pre-market trading following strong first-quarter earnings and upbeat second-quarter guidance.Pinterest's first-quarter revenue increased n
Earnings Call Summary | Inari Medical(NARI.US) Q1 2024 Earnings Conference
The following is a summary of the Inari Medical, Inc. (NARI) Q1 2024 Earnings Call Transcript:Financial Performance:Inari Medical reported Q1 2024 revenue of $143.2 million, representing an increase o
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)
Analysis
Price Target
No Data
